Abstract
Leading pharmaceutical companies are increasingly making biotech acquisitions to help them refill their pipelines, but what makes a good acquisition target and what will be the impact of the present financial crisis on deals. © 2009 Elsevier Ltd. All rights reserved.
Cite
CITATION STYLE
APA
Malik, N. N. (2009, September). Biotech acquisitions by big pharma: why and what is next. Drug Discovery Today. https://doi.org/10.1016/j.drudis.2009.06.012
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free